Discover

MTLS
Materialise NV
7.11
2 x 5.35
1 x 7.55
bid
ask
-
0.32
4.31%
2 @ 05:32 AM
6.91 -0.20 (2.81%)
Ytd28.11%
1y27.88%
7.05
day range
7.50
4.78
52 week range
7.50
Open7.43Prev Close7.43Low7.05High7.50Mkt Cap412.87M
Vol142.57KAvg Vol131.49KEPS0.19P/E37.42Forward P/E26.78
Beta1.11Short Ratio0.31Inst. Own13.08%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-0750-d Avg6.14200-d Avg5.741yr Est9.96
Earning
DateForEstimateReportedSurprisesurprise %
2024-10-242024-0900.06N/AN/A
2024-07-312024-0600.07N/AN/A
2024-04-252024-0300.07N/AN/A
2024-02-212023-1200.07N/AN/A
2023-10-262023-0900.07N/AN/A
2023-07-262023-060-0.01N/AN/A
Upgrade / Downgrade
DateFirmActionFromTo
2024-04-24Cantor FitzgeraldUpgradeOverweight
2023-04-28Lake StreetUpgradeBuy
2023-02-15Lake StreetUpgradeBuy
2021-10-20JP MorganUpgradeOverweight
2021-09-02StifelUpgradeBuy
2021-08-09Lake StreetUpgradeBuy
Profile
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Disciplined Growth Investors, Inc.1.60M11.58M2.71%
2024-09-29ARK Investment Management, LLC1.07M7.71M1.81%
2024-09-29Rock Point Advisors, LLC777.47K5.62M1.32%
2024-09-29Acadian Asset Management. LLC574.51K4.15M0.97%
2024-09-29Renaissance Technologies, LLC566.37K4.09M0.96%
2024-09-29KBC Group NV343.84K2.49M0.58%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-10-30ARK ETF Tr-ARK The 3D Printing ETF731.09K5.29M1.24%
2024-08-30Trust for Professional Managers-ActivePassive International Equity ETF49.61K358.71K0.08%
2024-09-29Collaborative Inv Ser Tr-Mercator International Opportunity Fd25.36K183.35K0.04%
2024-07-30Parametric International Equity Fund15.30K110.62K0.03%
2024-09-29SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF18.28K132.17K0.03%
2024-10-30ARK ETF Tr-ARK Autonomous Technology & Robotics ETF15.10K109.20K0.03%